Rifaximin
Indication
Preventing episodes of overt hepatic encephalopathy (NICE TA337)
NICE TA337 - Rifaximin for preventing episodes of overt hepatic encephalopathy
Amber level 0
Brand:
Targaxan®
Nice TA:
337
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Infection
Background
Recommended for preventing episodes of hepatic encephalopathy in people aged 18 years or older.
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: